Journal Article

β-Carotene breakdown products enhance genotoxic effects of oxidative stress in primary rat hepatocytes

A.J. Alija, N. Bresgen, O. Sommerburg, C.D. Langhans, W. Siems and P.M. Eckl

in Carcinogenesis

Volume 27, issue 6, pages 1128-1133
Published in print June 2006 | ISSN: 0143-3334
Published online January 2006 | e-ISSN: 1460-2180 | DOI: http://dx.doi.org/10.1093/carcin/bgi342
β-Carotene breakdown products enhance genotoxic effects of oxidative stress in primary rat hepatocytes

More Like This

Show all results sharing this subject:

  • Clinical Cytogenetics and Molecular Genetics

GO

Show Summary Details

Preview

Since it has to be expected that individuals exposed to oxidative stress who take supplements of β-carotene are simultaneously exposed to both β-carotene cleavage products (CPs) and oxidative stress, and both exposures have been demonstrated to cause genotoxic effects in primary rat hepatocytes, cyto- and genotoxic effects on primary rat hepatocytes after supplementation of the medium with increasing concentrations of a CP mixture during exposure to oxidative stress by treatment with either DMNQ (2,3-dimethoxy-1,4-naphthoquinone) or hypoxia/reoxygenation (Hy/Reox) was investigated. The cytological endpoints analysed were the mitotic indices, the percentages of apoptotic and necrotic cells, the percentages of micronucleated (MN) cells and the number of chromosomal aberrations (CAs) and sister chromatid exchanges (SCE). The results obtained clearly demonstrate that the CP mixture enhances the genotoxic effects of oxidative stress exposure, whereas it had no effect at all on the endpoints of cytotoxicity studied. These results further support the hypothesis that CP might be responsible for the reported carcinogenic response in the beta-CArotene and Retinol Efficacy Trial (CARET) and Alpha-Tocopherol Beta-carotene Cancer prevention (ATBC) chemoprevention trials.

Keywords: ATBC, Alpha-Tocopherol Beta-carotene Cancer prevention; CA, chromosomal aberration; CARET, beta-CArotene and Retinol Efficacy Trial; CP, cleavage product; Hy/Reox, hypoxia/reoxygenation; DMNQ, 2,3-dimethoxy-1,4-naphthoquinone; MEM, minimum essential medium; MN, micronucleated cells; SCE, sister chromatid exchange

Journal Article.  4180 words.  Illustrated.

Subjects: Clinical Cytogenetics and Molecular Genetics

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.